Daniel E. Troy holds the position of Chairman at National Chamber Litigation Center and Secretary & Director at Human Genome Sciences, Inc.
He is also on the board of NeuroRx, Inc. and NRX Pharmaceuticals, Inc. and Member of The American Law Institute.
In the past he occupied the position of Partner at Sidley Austin LLP, Senior Vice President & General Counsel at GlaxoSmithKline Plc, Chief Business & Administrative Officer at Valo Health, Inc., Chief Counsel at US Food & Drug Administration, Chairman of Civil Justice Reform Group, Chairman-Administrative Law Section at American Bar Association and Member-Law Review & Kent Scholar at Columbia Law School.
Mr. Troy received a graduate degree from Columbia Law School and an undergraduate degree from Cornell University.